Business Context and Reporting Period
This Form 8-K was filed by ARTELO BIOSCIENCES, INC. on July 13, 2021. The report discloses a corporate governance amendment effective immediately on the filing date.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a bylaws amendment and does not contain financial statements or performance data.
Material Changes
The Board of Directors amended Section 1.7 of the Company's Bylaws to update the definition of a quorum of shareholders at a meeting to 45%.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The document is limited to the procedural update of the Bylaws.
Key Facts for Investor Verification
- The quorum requirement for shareholder meetings has been set to 45%.
- The amendment was approved by the Board of Directors on July 13, 2021.
- The full text of the Bylaws Amendment is filed as Exhibit 3.1.
- No financial performance data is included in this specific filing.